Frontlight ResearchEarly access
Trial site
Staedtisches Krankenhaus Kiel GmbH
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Follicular lymphoma3 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Ovarian cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 312 trials
- Phase 42 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Astellas Pharma Global Development, Inc.2 trials
- AstraZeneca2 trials
- Regeneron Pharmaceuticals2 trials
- AGO Study Group1 trial
- BioNTech SE1 trial
- and 8 more
Running trials
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Follicular lymphoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026